Evidence map›Paper›PMID 26910387›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2016

Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.

Suzue Saito, Philani Mpofu, E Jane Carter, Lameck Diero, Kara K Wools-Kaloustian, Constantin T Yiannoutsos, Musick S Beverly, Simon Tsiouris, Geoffrey R Somi, John Ssali and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2018
    Article
  5. Article
  6. Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.Journal of acquired immune deficiency syndromes (1999) · 2017
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Suzue Saito*ICAP at Columbia University, New York, NY; †Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN; ‡Warren Alpert School of Medicine, Brown University, Providence, RI; §School of Medicine, Moi University, Eldoret, Kenya; ‖Academic Model Providing Access to Health Care (AMPATH), Eldoret, Kenya; ¶Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, IN; #Department of Biostatistics, Indiana University Fairbanks School of Public Health, Indianapolis, IN; **Currently Ridgewood Infectious Diseases, Ridgewood, NJ; ††National AIDS Control Programme (NACP), Dar-es-Salaam, Tanzania; ‡‡Masaka Regional Referral Hospital, Masaka, Uganda; §§Epidemiology and Biostatistics Program at the CUNY School of Public Health, New York, NY; and ‖‖Department of Epidemiology, Mailman School of Public Health, Columbia University, ICAP at Columbia University, New York, NY.
Philani Mpofu
E Jane Carter
Lameck Diero
Kara K Wools-Kaloustian
Constantin T Yiannoutsos
Musick S Beverly
Simon Tsiouris
Geoffrey R Somi
John Ssali
Denis Nash
Batya Elul
AMPATH · KEEunice Kennedy Shriver National Institute of Child Health and Human Development · USIndiana University – Purdue University Indianapolis · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional ConsortiumU01AI069911 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI AGGREY SEMWENDERO SEMEERE, Kara Kay Wools-Kaloustian · 2006 to 2026
$57.7M
The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MILTON L WAINBERG · 2003 to 2026
$48.2M
NIAID NIH HHS P30 AI027763NIAID NIH HHS U01 AI069911NIAID NIH HHS U01AI069911NIMH NIH HHS P30 MH043520
6 · The paper itself

Abstract

backgroundAntiretroviral therapy (ART) reduces the risk of Tuberculosis (TB) among people living with HIV (PLWH). With ART scale-up in sub-Saharan Africa over the past decade, incidence of TB among PLWH engaged in HIV care is predicted to decline.

methodsWe conducted a retrospective analysis of routine clinical data from 168,330 PLWH receiving care at 35 facilities in Kenya, Tanzania, and Uganda during 2003-2012, participating in the East African region of the International Epidemiologic Databases to Evaluate AIDS. Temporal trends in facility-based annual TB incidence rates (per 100,000 person years) among PLWH and country-specific standardized TB incidence ratios using annual population-level TB incidence data from the World Health Organization were computed between 2007 and 2012. We examined patient-level and facility-level factors associated with incident TB using multivariable Cox models.

resultsOverall, TB incidence rates among PLWH in care declined 5-fold between 2007 and 2012 from 5960 to 985 per 100,000 person years [P = 0.0003] (Kenya: 7552 to 1115 [P = 0.0007]; Tanzania: 7153 to 635 [P = 0.0025]; Uganda: 3204 to 242 [P = 0.018]). Standardized TB incidence ratios significantly decreased in the 3 countries, indicating a narrowing gap between incidence rates among PLWH and the general population. We observed lower hazards of incident TB among PLWH on ART and/or isoniazid preventive therapy and receiving care in facilities offering TB treatment onsite.

conclusionsAnnual TB incidence rates among PLWH significantly declined during ART scale-up but remained higher than the general population. Increasing access to ART and isoniazid preventive therapy and co-location of HIV and TB treatment may further reduce TB incidence among PLWH.

Indexed as

AdolescentAdultAnti-HIV AgentsFemaleHIV InfectionsHumansIncidenceKenyaMaleMiddle AgedRetrospective StudiesTanzaniaTime FactorsTuberculosisUgandaYoung AdultAnti-HIV Agents

Identifiers

PMID26910387
PMCPMC5902407
OpenAlexW2405958645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.